Challenges and Opportunities in Developing Tailored Pain Management Strategies for Liver Patients
- PMID: 38226103
- PMCID: PMC10789475
- DOI: 10.7759/cureus.50633
Challenges and Opportunities in Developing Tailored Pain Management Strategies for Liver Patients
Abstract
Chronic liver illnesses pose a substantial worldwide health challenge, with various causes that span from viral infections to metabolic problems. Individuals suffering from liver problems frequently face distinct difficulties in pain control, requiring a customized strategy that takes into account both the fundamental disease and the complexities of liver function. The liver, a vital organ responsible for metabolic control and detoxification, is pivotal in multiple physiological processes. Chronic liver illnesses, such as cirrhosis and non-alcoholic fatty liver disease (NAFLD), are marked by a gradual process of inflammation and fibrosis, resulting in reduced liver function. These disorders often come with pain, varying from internal discomfort to intense abdominal pain, which impacts the quality of life and general well-being of patients. The review explores the complex aspects of pain perception in liver illnesses, including inflammation, modified neuronal signaling, and the influence of comorbidities. It highlights the significance of a detailed comprehension of the pain experience in individuals with hepatic conditions for the implementation of successful pain management treatments. In addition, the review emphasizes the difficulties involved in treating pain in this group of patients, such as the possible complications linked to commonly prescribed pain relievers and the necessity for collaboration between hepatologists, pain specialists, and other healthcare professionals. Moreover, it examines new possibilities in the domain, such as the significance of innovative pharmacological substances, non-pharmacological treatments, and personalized medicine strategies designed for specific patient characteristics. This study thoroughly analyzes the difficulties and possibilities involved in creating personalized pain management approaches for individuals with liver conditions. Its purpose is to guide physicians, researchers, and healthcare providers, enabling them to implement more efficient and patient-focused interventions. As our comprehension of liver-related pain progresses, the potential for enhancing the quality of life for persons with chronic liver disorders through tailored pain management measures becomes more and more encouraging.
Keywords: chronic liver conditions; interdisciplinary collaboration; liver diseases; pain management; precision medicine; tailored interventions.
Copyright © 2023, Majid et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease.Cureus. 2023 Oct 13;15(10):e46946. doi: 10.7759/cureus.46946. eCollection 2023 Oct. Cureus. 2023. PMID: 38021670 Free PMC article. Review.
-
Diagnosis and Treatment of Liver Disease: Current Trends and Future Directions.Cureus. 2023 Dec 4;15(12):e49920. doi: 10.7759/cureus.49920. eCollection 2023 Dec. Cureus. 2023. PMID: 38174191 Free PMC article. Review.
-
The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.JHEP Rep. 2022 Jun 15;4(9):100525. doi: 10.1016/j.jhepr.2022.100525. eCollection 2022 Sep. JHEP Rep. 2022. PMID: 36039144 Free PMC article.
-
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.Gastroenterology. 2022 Sep;163(3):764-774.e1. doi: 10.1053/j.gastro.2022.06.023. Epub 2022 Jul 14. Gastroenterology. 2022. PMID: 35842345 Free PMC article.
Cited by
-
To Be in Pain: Pain Multidimensional Questionnaire as Reliable Tool to Evaluate Multifaceted Aspects of Pain.J Clin Med. 2024 Oct 2;13(19):5886. doi: 10.3390/jcm13195886. J Clin Med. 2024. PMID: 39407946 Free PMC article.
-
Biochemical strategies for opioid-sparing pain management in the operating room.Biochem Biophys Rep. 2025 Jan 25;41:101927. doi: 10.1016/j.bbrep.2025.101927. eCollection 2025 Mar. Biochem Biophys Rep. 2025. PMID: 40134940 Free PMC article. Review.
References
-
- Global reporting of progress towards elimination of hepatitis B and hepatitis C. Cui F, Blach S, Manzengo Mingiedi C, et al. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Lancet Gastroenterol Hepatol. 2023;8:332–342. - PubMed
-
- Management of cancer pain in adult patients: ESMO clinical practice guidelines. Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI. https://doi.org/10.1093/annonc/mds233 Ann Oncol. 2018;29:0–91. - PubMed
-
- Understanding the psychological, physiological, and genetic factors affecting precision pain medicine: a narrative review. Chadwick A, Frazier A, Khan TW, Young E. https://doi.org/10.1093/pm/pny036. J Pain Res. 2021;14:3145–3161. - PMC - PubMed
-
- Interventions to facilitate shared decision-making using decision aids with patients in primary health care: a systematic review. Coronado-Vázquez V, Canet-Fajas C, Delgado-Marroquín MT, Magallón-Botaya R, Romero-Martín M, Gómez-Salgado J. https://doi.org/10.1016/j.mayocp.2014.01.019 Medicine (Baltimore) 2020;99:0. - PMC - PubMed
-
- Cirrhosis. Wilson R, Williams DM. https://doi.org/10.1002/hep.22757. Med Clin North Am. 2022;106:437–446. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials